23 Feb ElevateBio
Kareem Reda, Chief Business Officer
Oct. 13 | 1:30pm | BlueRock Therapeutics Ballroom
ElevateBio is a cell and gene therapy technology company built to power the development of transformative cell and gene therapies today and for decades to come. The company has assembled industry-leading talent, built world-class facilities, and integrated diverse technology platforms necessary for rapid innovation and commercialization of cell, gene, and regenerative therapies. ElevateBio has built an initial technology stack, including gene editing, induced pluripotent stem cells, and protein, viral, and cellular engineering. At the center of the business model is ElevateBio BaseCamp, a centralized R&D and manufacturing company offering research and development, process development, and cGMP manufacturing capabilities. ElevateBio is focused on increasing long-term collaborations with industry partners while developing its own highly innovative cell and gene therapies. ElevateBio’s team of scientists, drug developers, and company builders are redefining what it means to be a technology company in the world of drug development, blurring the line between technology and healthcare.